Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.66 | 0.01 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |